These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6126195)

  • 1. The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
    Cooney DA; Jayaram HN; Gebeyehu G; Betts CR; Kelley JA; Marquez VE; Johns DG
    Biochem Pharmacol; 1982 Jun; 31(11):2133-6. PubMed ID: 6126195
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
    Jayaram HN; Ahluwalia GS; Dion RL; Gebeyehu G; Marquez VE; Kelley JA; Robins RK; Cooney DA; Johns DG
    Biochem Pharmacol; 1983 Sep; 32(17):2633-6. PubMed ID: 6137224
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
    Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide.
    Kuttan R; Robins RK; Saunders PP
    Biochem Biophys Res Commun; 1982 Aug; 107(3):862-8. PubMed ID: 6127996
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase.
    Gebeyehu G; Marquez VE; Kelley JA; Cooney DA; Jayaram HN; Johns DG
    J Med Chem; 1983 Jun; 26(6):922-5. PubMed ID: 6133956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.
    Gebeyehu G; Marquez VE; Van Cott A; Cooney DA; Kelley JA; Jayaram HN; Ahluwalia GS; Dion RL; Wilson YA; Johns DG
    J Med Chem; 1985 Jan; 28(1):99-105. PubMed ID: 2856943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrogenase binding by tiazofurin anabolites.
    Goldstein BM; Bell JE; Marquez VE
    J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
    Jayaram HN; Smith AL; Glazer RI; Johns DG; Cooney DA
    Biochem Pharmacol; 1982 Dec; 31(23):3839-45. PubMed ID: 6130768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).
    Ahluwalia GS; Cooney DA; Marquez VE; Jayaram HN; Johns DG
    Biochem Pharmacol; 1986 Nov; 35(21):3783-90. PubMed ID: 2877671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of inosinate dehydrogenase.
    Kuttan R; Saunders P
    Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y; Natsumeda Y; Weber G
    Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).
    Jayaram HN; Cooney DA; Glazer RI; Dion RL; Johns DG
    Biochem Pharmacol; 1982 Aug; 31(15):2557-60. PubMed ID: 7126269
    [No Abstract]   [Full Text] [Related]  

  • 14. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
    Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
    J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
    Jayaram HN; Dion RL; Glazer RI; Johns DG; Robins RK; Srivastava PC; Cooney DA
    Biochem Pharmacol; 1982 Jul; 31(14):2371-80. PubMed ID: 6127085
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
    Balzarini J; Stet L; Matsuda A; Wiebe L; Knauss E; De Clercq E
    Adv Exp Med Biol; 1998; 431():723-8. PubMed ID: 9598159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.